Product not yet rated
Includes a Live Web Event on 02/18/2025 at 11:00 AM (PST)
Content provided by Baxter (No CE credits offered)
Webinar Description:
Endotoxin plays a prominent role in the pathogenesis of sepsis and often comes from the gut and the idea of neutralizing its detrimental capacities. All Gram-negative bacteria have a cell wall made up of endotoxins and can activate the immune system in many ways at low or toxic level. Eight out of 12 of the most dangerous bacteria cited by the World Health Organization to encourage treatment strategies are gram negative species. In addition to delving into early recognition and treatment of sepsis using the bundles, this sponsored session will explore recognition of endotoxin and innovative treatment options.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Baxter for this sponsored webinar.
Kathleen M. Vollman, MSN, RN, CCNS, FCCM, FCNS, FAAN
Clinical Nurse Specialist/Consultant
ADVANCING NURSING, LLC
Kathleen M. Vollman MSN, RN, CCNS, FCCM, FCNS, FAAN, is a Critical Care Clinical Nurse Specialist and Consultant. Kathleen received her BSN from Wayne State University in Detroit and her Master as Critical Care Clinical Nurse Specialist from California State University Long Beach. She has published and lectured nationally and internationally on a variety of topics including pulmonary, critical care, prevention of health care acquired injuries including pressure injury and CAUTI/CLABSIs and other HAIs, work culture, and sepsis recognition and management. She serves as a subject matter expert on these topics for the American Hospital Association and Michigan Hospital Association. From 1989 to 2003, she functioned in the role of Clinical Nurse Specialist for the Medical ICUs at Henry Ford Hospital in Detroit, Michigan. Currently, her company, ADVANCING NURSING LLC, is focused on creating empowered work environments for healthcare practitioners through the acquisition of better skills, attainment of greater knowledge, and implementation of process improvement.
Please feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this webinar/course.
Product not yet rated
Includes a Live Web Event on 01/16/2025 at 12:00 PM (PST)
Attendees will gain valuable insights into upcoming CMS and CDC-developed measures that will deliver actionable data, enhancing hospitals' ability to provide effective care for patients with sepsis.
Description:
Date: January 16, 2025
Time: 3:00 - 4:00 pm ET / 12:00 pm - 1:00 pm PT
During this webinar, the Director of the Center for Disease Control and Prevention’s (CDC) National Center for Emerging and Zoonotic Infectious Diseases in the Division of Healthcare Quality Promotion will review how CDC is working with partner organizations across the nation to advance and support continuous sepsis quality improvement work and outcomes.
Attendees will gain valuable insights into upcoming CMS and CDC-developed measures that will deliver actionable data, enhancing hospitals' ability to provide effective care for patients with sepsis.
Learning Objectives:
At the end of the activity, the learner should be able to:
Identify how CDC is working with partners to advance sepsis quality improvement and how these strategies could be applied to advance sepsis quality improvement at their own organization.
Describe how forthcoming CMS and CDC-developed measures will provide insight and actionable data on how hospitals are able to care for patients with sepsis.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporters:
Sepsis Alliance gratefully acknowledges the support provided for this webinar by the Sepsis Alliance Institute sponsors.
Michael Bell, MD
Director, Center for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion
Department of Health and Human Services, Centers for Disease Control and Prevention (CDC)
Michael Bell, MD, is the Director of National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) Division of Healthcare Quality Promotion (DHQP). He served as Deputy Director of DHQP from 2010 to 2023 before being selected as Acting Director and ultimately Director in 2024.
DHQP promotes the protection of patients and healthcare personnel and improvements in the safety and quality of health care. Examples of activities include producing guidelines for the prevention of healthcare-associated infections (HAI), programs for combating antimicrobial resistance (AR), and improvements in basic safe medical practices such as safe injections.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hour.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
Please feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this webinar/course.
Includes a Live Web Event on 12/12/2024 at 8:00 AM (PST)
Live symposium featuring various aspects of healthcare-associated infections and sepsis.
Description:
Date: December 12, 2024
Time: 10:00 am - 3:00 pm ET / 7:00 am - 12:00 pm PT
Healthcare-associated infections (HAIs) are the most common challenge in hospital settings, posing significant risks for both patients and healthcare providers. According to the Centers for Disease Control and Prevention (CDC), one in every 31 hospital patients contracts at least one HAI daily, leading to substantial financial burdens for healthcare organizations. The risk of HAIs escalating into sepsis underscores the critical need for effective prevention measures.
Healthcare professionals must prioritize the identification and implementation of strategies to improve performance and outcomes in preventing HAIs and sepsis across all departments and specialties.
Sepsis Alliance is hosting the 2024 Sepsis Alliance Symposium: Healthcare-Associated Infections to continue our mission and further the idea that infection prevention is sepsis prevention. This engaging virtual event will take place on December 12, 2024, and will delve into essential topics surrounding HAIs. Attendees will gain access to cutting-edge clinical insights and the latest recommendations for preventing and treating infections. This half-day symposium aims to highlight the importance of HAI prevention in clinical practice, ultimately striving to improve patient outcomes and reduce the incidence of sepsis.
Central line-associated bloodstream infections (CLABSI)
HAI surveillance: Past, present, and future
Preventing healthcare-associated infections in surgical patients
Learning Objectives:
At the end of the activity, the learner should be able to:
Demonstrate increased knowledge relating to maintaining a compliant and effective infection prevention and control program in the healthcare setting;
Describe examples of infection prevention and control evidence-based best practices and recommendations;
Propose innovative approaches, protocols, tools and documentation for limiting healthcare-associated infections.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Symposium Supporters:
Sepsis Alliance gratefully acknowledges the support provided for this symposium by the following sponsors:
Kidney Care
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 3.6 contact hours.
Other healthcare professionals will receive a certificate of attendance for 3.0 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
Welcome & Opening Remarks
Time: 10:00 - 10:10 AM ET
Session 1 Infection Prevention in Action: Partnering to Enhance Healthcare-Associated Infections (HAIs) and Sepsis Prevention Strategies
Time: 10:10 - 10:40 AM ET
This presentation will discuss the similarities in prevention approaches for HAI and sepsis. Learn how interdisciplinary collaboration among healthcare professionals and infection preventionists can significantly enhance infection prevention efforts to minimize both HAIs and preventable sepsis risks. This presentation aims to equip attendees with the necessary knowledge to improve patient outcomes through effective infection prevention practices.
Learning Objectives:
Identify and compare the prevention strategies for healthcare-associated infections (HAIs) and sepsis, highlighting both their shared approaches and unique considerations;
Describe how interdisciplinary collaboration among healthcare professionals, infection preventionists, and other stakeholders enhances the effectiveness of prevention efforts;
Recognize common barriers to implementing HAI and sepsis prevention strategies and discuss actionable solutions to address these challenges in healthcare settings.
Session 2 HAP, VAP, and All of That
Time: 10:40 - 11:10 AM ET
During this presentation, learners will have the opportunity to review the definitions and epidemiology of ventilator-associated events, ventilator-associated pneumonia, and non-ventilator hospital-acquired pneumonias. The session will also explore the pathophysiology and impact of co-infections related to hospital-acquired pneumonias, as well as strategies to prevent hospital-acquired pneumonia.
Learning Objectives:
Understand the definitions and epidemiology of ventilator-associated-events, ventilator-associated pneumonia, and non-ventilator hospital-acquired pneumonia;
Describe the epidemiology and pathophysiology of hospital-acquired pneumonias, including the impact of co-infections;
Recognize strategies to prevent pneumonia within the hospital.
Sponsor Session 1 BD Sponsored Session: Clinical Burden of Hospital Onset Bacteremia and Fungemia (HOB)
Time: 11:25 - 11:40 AM ET
Hospital Onset Bacteremia & Fungemia (HOB) is a new metric proposed by the CDC for National Healthcare Safety Network (NHSN) volunteer reporting. This sponsored presentation will delve into recent research papers that elucidate the differences between HOB and Central Line-associated Bloodstream Infection (CLABSI), the impact of urine sources on Catheter Associated Urinary Tract Infections (CAUTI) and non-catheter Hospital Onset UTIs contributing to HOB, the burden of Surgical Site Infections (SSI) associated with HOB, and the overall clinical and health economic significance of HOB.
Session 3 Health Inequity in Healthcare-Associated Infections and Antimicrobial Resistance
Time: 11:40 AM - 12:10 PM ET
This presentation explores the complex relationship between healthcare-associated infections (HAIs), antimicrobial resistance (AMR), and health inequities. Recent evidence that highlights disparities in HAI and AMR burdens will be examined, identifying critical factors that drive these inequities including variations in care quality and social determinants of health. Insights into targeted interventions designed to address and reduce these disparities, contributing to more equitable outcomes in infection prevention and resistance management, will also be discussed.
Learning Objectives:
Review current evidence of inequities in the burden of healthcare-associated infections (HAIs) and antimicrobial resistance (AMR);
Describe how differences in quality of care and social determinants of health can contribute to HAI and AMR risk;
List interventions that may help us to eliminate inequities in HAI and AMR risk
Sponsor Session 2 BD Sponsored Session: The Impact of Drug-Resistant Infections in the Cancer Community
Time: 12:10 - 12:40 PM ET
Nearly 100 years ago, scientists handed the world a new miracle drug: antibiotics. This revolutionized healthcare, improving the length and quality of our lifespans. Modern medicine has been built on the bedrock of being capable of controlling infections while treating aggressive disease. We stand on the precipice of losing this ability, as antimicrobial resistance (AMR) threatens to overwhelm our antibiotic and antifungal supply. Nowhere is this more concerning than in the cancer community. This sponsored presentation will review current literature analyzing the impact of AMR on the cancer community and will provide an overview of suggested actions we can take to reduce the risk of drug-resistant infections.
Session 4 Prevention of CRBSIs in Healthcare Settings
Time: 12:55 - 1:25 PM ET
This presentation focuses on preventing catheter-related bloodstream infections (CRBSIs) in healthcare settings, highlighting the critical role of identifying and mitigating sources of infection. Attendees will gain insights into effective strategies for reducing the risk of these infections, with a special focus on antimicrobial lock therapy as a preventative measure. The session aims to equip healthcare professionals with practical knowledge to enhance patient safety and infection control practices related to intravascular catheter use.
Learning Objectives:
Identify the predominant sources of microbes causing intravascular catheter infections;
List strategies to reduce risk of intravascular catheter infections;
Describe antimicrobial lock therapy for prevention of intravascular catheter infections.
Session 5 Compendium of Strategies to Prevent CAUTIs: 2022 Updates
Time: 1:25 - 1:55 PM ET
This presentation offers a comprehensive overview of the latest methods to prevent catheter-associated urinary tract infections (CAUTIs). Recent changes and additions to the CAUTI Compendium, providing participants with updated strategies to minimize infection risks, will be covered. Attendees will also learn how to incorporate diagnostic and antimicrobial stewardship into their CAUTI prevention practices effectively. Additionally, the differences between infectious and noninfectious harms linked to CAUTIs will be explored, equipping healthcare professionals with the knowledge to improve patient outcomes.
Sponsor Session 3 CorMedix Sponsored Session: Reducing the Risk of Catheter Related Blood Stream Infections in Hemodialysis Patients
Time: 1:55 - 2:10 PM ET
In this sponsored session, learn about the risks of catheter related blood stream infections in hemodialysis patients. Opportunities for prevention will also be discussed, including the clinical data for a recent FDA-approved catheter lock solution. The presenter will cover ways for healthcare teams to work together to improve patient outcomes.
Sponsor Session 4 Wolters Kluwer Sponsored Session: SIR, SUR & CAD: Evaluate & Elevate Your Infection Prevention & Control Performance
Time: 2:10 - 2:25 PM ET
Infection Prevention leaders are often challenged with how to best evaluate their Infection Prevention & Control (IPC) program performance while also considering the unique attributes of their organization and patients they serve. As 2024 comes to a close, now is the time to revisit key performance indicators such as Standardized Infection Ratio (SIR), Standardized Utilization Ratio (SUR), and Cumulative Attributable Difference (CAD) to further enhance your IPC program in the new year. This Wolters Kluwer sponsored session recaps best practices when evaluating your IPC program performance, including reviewing the role of risk adjustment, discussing the value of readily available metrics, and sharing tips to consider in your own practice. Join our expert to ensure your program is set up for success in 2025!
Session 6
Strategies for Preventing C. difficile Infections in Hospitals
Time: 2:25 - 2:55 PM ET
This presentation will explore the current landscape of C. difficile infections in U.S. hospitals, emphasizing the urgency of addressing this persistent healthcare challenge. Attendees will gain insights into the most effective infection prevention strategies, including well-established and emerging practices. The session will also address the complexities and ongoing debates around additional preventative measures, offering a comprehensive understanding of how hospitals can enhance patient safety and reduce infection rates.
Learning Objectives:
Define trends in C. difficile infections in the US;
Identify essential strategies that all hospitals should implement for prevention of C. difficile infections;
Describe additional and unresolved strategies for prevention of C. difficile infections in hospitals.
Session 7
Time: 2:55 - 3:25 PM ET
More information to come.
Closing Remarks: Key Takeaways
Time: 3:25 - 3:30 PM ET
Time (ET)
Session Title
Presenter
10:00-10:10
Welcome and Opening Remarks
10:10-10:40
Session 1: Infection Prevention in Action: Partnering to Enhance Healthcare-Associated Infections (HAIs) and Sepsis Prevention Strategies
Stephanie Holley, MBA, BSN, RN, CIC, FAPIC Director IPC Education and Professional Development Association of Professionals in Infection Control and Epidemiology (APIC)
10:40-11:10
Session 2: HAP, VAP, and All of That
Kelly Cawcutt, MD, MS, FACP, FIDSA, FCCM Associate Professor, Infectious Diseases & Critical Care Medicine Medical Director of Infection Control
University of Nebraska Medical Center
11:10-11:25
Break
11:25-11:40
BD Sponsored Session: The Impact of Drug-Resistant Infections in the Cancer Community
Diane Flayhart, MS Director, Global Public Health BD
11:40-12:10
Session 3: Health Inequity in Healthcare-Associated Infections and Antimicrobial Resistance
David Calfee, MD, MS Director of the Healthcare-Associated Infections Division / Senior Science Advisor Center for Quality Improvement and Patient Safety (CQuIPS) Agency for Healthcare Research and Quality, US Department of Health and Human Services
12:10-12:40
BD Sponsored Session: Clinical Burden of Hospital Onset Bacteremia and Fungemia (HOB)
Kalvin Yu, MD, FIDSA
Vice President of Medical Affairs, North America, BD Samantha Bastow, PharmD, MBA Associate Director, Clinical Integration, Medical Affairs, US Region, BD
12:40-12:55
Break
12:55-1:25
Session 4: Prevention of CRBSIs in Healthcare Settings
Leonard A. Mermel, DO, ScM, AM (Hon), FSHEA, FIDSA, FACP Professor of Medicine Warren Alpert Medical School of Brown University
Medical Director, Dept. of Epidemiology & Infection Prevention Brown University Health
Adjunct Clinical Professor University of Rhode Island College of Pharmacy
1:25-1:55
Session 5: Compendium of Strategies to Prevent CAUTIs: 2022 Updates
Payal Patel, MD, MPH, FIDSA System-Wide Medical Director of Antimicrobial Stewardship, Associate Professor Intermountain Health
1:55-2:10
CorMedix Sponsored Session: Reducing the Risk of Catheter Related Blood Stream Infections in Hemodialysis Patients
Anil Agarwal, MBBS, MD, FACP, FASN, FISN, FNKF, FASDIN Professor of Medicine University of California San Francisco
2:10-2:25
Wolters Kluwer Sponsored Session: SIR, SUR & CAD: Evaluate & Elevate Your Infection Prevention & Control Performance
Matt Weissenbach, DrPH, CPH, CIC, FAPIC Senior Director of Clinical Affairs Wolters Kluwer
2:25-2:55
Session 6: Strategies for Preventing C. difficile Infections in Hospitals
Larry K. Kociolek, MD, MSCI, FSHEA, FPIDS Vice President, System Preparedness, Prevention, and Response; Attending Physician, Division of Infectious Diseases; Ann & Robert H. Lurie Children’s Hospital of Chicago
Anil K. Agarwal, MD, FACP, FASN, FISN, FNKF, FASDIN, is the Chief of Medicine at Veterans Affairs Central California Health Care System at Fresno, California and a Professor of Clinical Medicine at The University of California San Francisco at Fresno. Dr. Agarwal is a passionate clinician, educator, and author, and is an internationally recognized expert in hypertension, chronic kidney disease, dialysis, anemia, mineral bone disorders, and vascular access. He has conducted over 50 clinical trials, developed protocols, and published results of studies. He is a frequently sought speaker nationally and internationally. He serves and chairs many committees and boards, and also serves as editor and reviewer for several medical journals.
Samantha Bastow, PharmD, MBA
Associate Director, Clinical Integration, Medical Affairs, US Region
BD
As the Associate Director of Clinical Integration in Medical Affairs at BD, Samantha Bastow, PharmD, MBA, is responsible for overseeing and managing both the clinical and administrative aspects of the medical division of business. This includes innovation and new product and business development, lifecycle clinical evidence generation, market shaping and development, and safety and compliance. Prior to BD, she served as the Director of Clinical Pharmacy Services at the University of Chicago Medical Center, where she led inpatient and emergency clinical pharmacy service lines, including antimicrobial stewardship, in addition to formulary management, clinical decision support, business development, research and academic responsibilities. Samantha holds a PharmD from Palm Beach Atlantic University and an MBA with a specialization in data analytics from the University of Illinois. She completed a PGY1 residency at Sarasota Memorial Hospital followed by an emergency medicine pharmacy residency at Boston Medical Center.
David Calfee, MD, MS
Director of the Healthcare-Associated Infections Division / Senior Science Advisor
Center for Quality Improvement and Patient Safety (CQuIPS), Agency for Healthcare Research and Quality, US Department of Health and Human Services
David P. Calfee, MD, MS, is an infectious disease physician and healthcare epidemiologist who serves as Senior Science Advisor and the Director of the Healthcare-Associated Infection (HAI) Division within the Center for Quality Improvement and Patient Safety (CQuIPS) at the Agency for Healthcare Research and Quality (AHRQ). Prior to joining AHRQ, Dr. Calfee was a Professor of Medicine and Population Health Sciences at Weill Cornell Medicine, in New York, NY. He also served as the Chief Hospital Epidemiologist for NewYork-Presbyterian/Weill Cornell Medical Center. He has more than 20 years of experience in implementation and management of infection prevention and control programs and has conducted clinical research on healthcare-associated infections, antimicrobial resistance, and antimicrobial stewardship in a variety of healthcare settings. He currently also serves as the Editor-in-Chief of Infection Control & Hospital Epidemiology.
Kelly Cawcutt, MD, MS, FACP, FIDSA, FCCM
Associate Professor, Infectious Diseases & Critical Care Medicine / Medical Director of Infection Control
University of Nebraska Medical Center
Kelly Cawcutt, MD, MS, FACP, FIDSA, FCCM, is an Associate Professor of Medicine and board certified in Critical Care Medicine and Infectious Diseases at University of Nebraska Medical Center (UNMC) in Omaha. She is the Medical Director of Medical Quality and an Associate Director of Infection Prevention and Hospital Epidemiology for Nebraska Medicine; and Co-Director of Digital Innovation and Social Media Strategy for the Infectious Diseases Division of UNMC. Nationally, she is involved with the Infectious Diseases Society of America (IDSA), the Society of Critical Care Medicine (SCCM), and the Society for Healthcare Epidemiology of America (SHEA). Dr. Cawcutt’s research interests include infections in the intensive care unit, with focus on hospital-acquired infections.
Diane Flayhart, MS
Director, Global Public Health
BD
As a Director in Global Public Health at BD, Diane Flayhart, MS, is responsible for leading global policy and advocacy efforts on antimicrobial resistance. She works with global stakeholders in a collaborative and programmatic approach to strengthen healthcare systems. She also leads efforts for the Antimicrobial Resistance Fighter Coalition, a global organization that seeks to increase awareness of drug-resistant infections and encourage action. Prior to joining BD, Diane managed the clinical microbiology laboratory at The Johns Hopkins Hospital.
Stephanie Holley, MBA, BSN, RN, CIC, FAPIC
Director IPC Education and Professional Development
Association of Professionals in Infection Control and Epidemiology (APIC)
Stephanie Holley, MBA, BSN, RN, CIC, FAPIC, has been an infection preventionist for the past 25 years. She began her healthcare journey as a registered nurse providing care for med/surg and oncology patients and spent time in the perioperative environment. She made a move from direct patient care to joining the University of Iowa’s Program of Hospital Epidemiology where she was the Lead Infection Preventionist. Recently, Stephanie transitioned from a member to staff role at the Association for Professionals in Infection Control and Epidemiology (APIC), where she now serves as Director of Infection Prevention & Control (IPC), Education & Professional Development.
Larry K. Kociolek, MD, MSCI, FSHEA, FPIDS
Vice President, System Preparedness, Prevention, and Response
Ann & Robert H. Lurie Children’s Hospital of Chicago
Larry K. Kociolek, MD, MSCI, FSHEA, FPIDS, is an Attending Physician in the Division of Pediatric Infectious Diseases and Vice President of System Preparedness, Prevention, and Response at Ann & Robert H. Lurie Children’s Hospital of Chicago, and he is an Associate Professor of Pediatrics at Northwestern University Feinberg School of Medicine. At Lurie Children’s, Dr. Kociolek leads preparedness, prevention, and response efforts for all hazards, including emerging pathogens. He serves as site PI for the HRSA-funded Pediatric Pandemic Network.
Dr. Kociolek is the Principal Investigator of several NIH-funded translational research studies focused on the epidemiology and prevention of healthcare-associated and other high-consequence infections in children, particularly C. difficile infection and COVID-19. He serves on the Pediatric Leadership Council for the Society for Healthcare Epidemiology of America (SHEA) whose goal is to lead national advocacy, research, and education efforts for prevention of healthcare-associated infections in children. Through SHEA, he has led an international group of experts to define best practices for the prevention of C. difficile infections in adults and children in acute care hospitals.
Leonard A. Mermel, DO, ScM, AM (Hon), FSHEA, FIDSA, FACP
Professor of Medicine
Warren Alpert Medical School of Brown University
Leonard A. Mermel, DO, ScM, AM (Hon), FACP, FIDSA, FSHEA, is a Professor of Medicine at Warren Alpert Medical School of Brown University, an Adjunct Clinical Professor at the University of Rhode and College of Pharmacy, and a Medical Director of the Department of Epidemiology & Infection Prevention for the Lifespan Hospital System. Dr. Mermel was a Technical Expert Panel Member of the Center for Medicare & Medicaid Services (CMS) Patient Safety Monitoring System and is a Subject Matter Expert for the AHRQ Safety Program for HAI Prevention. He was 2005 President of the Society for Healthcare Epidemiology of America (SHEA) and the 2014 SHEA Mentor Scholar Award recipient.
Dr. Mermel is a member of the World Health Organization (WHO) Guideline Development Group for the prevention of bloodstream infections and other infections associated with intravascular catheters. He has co-authored U.S. guidelines dealing with prevention and management of intravascular catheter infections and co-authored 400 articles, textbook chapters, and abstracts dealing with infection prevention and infectious diseases. As of October 2024, his H-Index is 58 and Sum of Times Cited is 32,119. Drs. Mermel and Classen developed the idea for the Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals, a standard guidance used in the U.S. and the basis for some National Patient Safety Goals. He is Co-Course Director of the Annual Fellows Course in Healthcare Epidemiology, Infection Prevention, and Antimicrobial Stewardship. He has lectured at the National Institutes of Health, Institute of Medicine, NASA Johnson Space Center, and internationally on infectious disease issues. His research focus has been the prevention of healthcare-associated infections.
Payal Patel, MD, MPH, FIDSA
System-Wide Medical Director of Antimicrobial Stewardship, Associate Professor
Intermountain Health
Payal Patel, MD, MPH, FIDSA, is an associate professor at Intermountain Health and the systemwide medical director of antimicrobial stewardship. She is an infectious diseases physician and is passionate about improving patient safety and antimicrobial stewardship. Dr. Patel serves on the Presidential Advisory Council on Combatting Antibiotic Resistance and has worked with developing antimicrobial stewardship programs in several countries including India, Japan, and Italy. She is the lead author on the most recent CAUTI compendium.
Matt Weissenbach, DrPH, CPH, CIC, FAPIC
Senior Director of Clinical Affairs
Wolters Kluwer
Matt Weissenbach, DrPH, CPH, CIC, FAPIC, is the Senior Director of Clinical Affairs with Wolters Kluwer. He is responsible for leading clinical efforts in the design, development, implementation, and support of Wolters Kluwer Clinical Surveillance software solutions. He and his team focus on building strong clinical partnerships and supporting healthcare teams with guidance and resources to provide high-quality care and reach optimal patient outcomes. Dr. Weissenbach has practiced as an epidemiologist and infection preventionist for more than fifteen years. His practice and research interests include the role of clinical decision support and technology in advancing infection prevention and the implementation science of multidisciplinary approaches in antimicrobial stewardship. He earned his Doctor of Public Health and Master of Public Health degrees from the University of South Florida (USF) College of Public Health. He also serves as adjunct faculty at USF, teaching and mentoring students on emerging infectious diseases, epidemiology, and the principles of infection prevention and control. Dr. Weissenbach is board-certified in infection control and epidemiology (CIC®) and public health (CPH®). He received the designation of Fellow of the Association for Professionals in Infection Control and Epidemiology (FAPIC®) in 2020 and serves as an active member of both APIC and the Society for Healthcare Epidemiology of America.
Kalvin Yu, MD, FIDSA
Vice President of Medical Affairs, North America
BD
As the Vice President of Medical Affairs for North America, Kalvin Yu, MD, FIDSA, is responsible for providing medical and scientific leadership and operationally viable BD Solutions with clinicians and healthcare systems across the United States. Before BD, Dr. Yu was the Chief Integration Officer and Chief of Infectious Diseases at Southern California Kaiser Permanente, where he implemented multidisciplinary quality and patient safety programs among different hospitals and service lines. Dr. Yu trained at the UCLA School of Medicine and was a former Associate Professor of Infectious Disease and Global Public Health at NYU. Published research areas include patient outcomes, readmissions, and quality metric benchmarking. He was a member of the CDC Antibiotic Utilization workgroup, and has been an invited speaker at IDSA, SHEA, Pew Trusts, and Capitol Hill in Washington D.C. Dr. Yu was nominated and inducted as a Fellow in the Infectious Diseases Society of America in 2020.
Please feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this symposium.
Includes a Live Web Event on 12/03/2024 at 11:00 AM (PST)
Content provided by Wolters Kluwer (No CE credits offered)
Webinar Description:
Sponsored by Wolters Kluwer
As 2024 comes to a close, now is the time to look back and develop a plan to enhance your Infection Prevention and Control Program in the new year. This sponsored webinar will recap infection prevention updates and challenges over the past year - reviewing updated reporting requirements, analyzing new research findings, and sharing new collaborative publications from professional organizations. Join our expert to ensure your program is set up for success in 2025!
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Wolters Kluwer for this sponsored webinar.
Karen Jones, MPH, RN, CIC, LTC-CIP, FAPIC
Infection Prevention Clinical Program Manager
Wolters Kluwer
Karen Jones, MPH, RN, CIC, LTC-CIP, FAPIC, is an Infection Prevention Clinical Program Manager for Wolters Kluwer. In this role, she is responsible for the development, design and implementation of evidence-based content while being a resource for infection preventionists.
Prior to joining Wolters Kluwer in 2023, Karen spent five years managing several grant-funded infection prevention clinical research projects at the University of Michigan. Between 2009 to 2023, she held the role of infection preventionist at a large academic medical center in Detroit, covering tasks from full-time infection preventionist to conducting remote surveillance for the health system. She was a subject matter expert for the CDC/STRIVE Infection Control Training project, presenting nationally on a variety of topics. She has published several peer-reviewed manuscripts on both acute and long-term care infection prevention topics. Prior to infection prevention, she was an emergency department nurse in a Level 1 trauma center and certified forensic nurse examiner in Detroit, MI.
Karen received her Bachelor of Science in Nursing degree from Concordia University Chicago and Master of Public Health from Benedictine University in Lisle, Illinois. She achieved board certification in infection control (CIC®) in 2016 and long-term care (LTC-CIP®) in 2021. She received the designation of Fellow of the Association for Professionals in Infection Control (FAPIC®) in 2019. She is involved in her state APIC chapter, previously holding the roles of president-elect and treasurer.
Please feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this webinar/course.
Content provided by AgileMD (No CE credits offered)
Webinar Description:
Date: November 19, 2024
Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT
In the fight to solve sepsis, new AI powered tools have emerged to support clinicians on the front lines of patient care. Yet, not all AI is created equally, and clinical leaders need to know how to compare solutions. Further, clinical leaders need strategies for implementing AI tools successfully, because even the most advanced technology won’t save a single life if it isn’t used. This sponsored webinar will bring together experts in clinical research and quality implementation to educate attendees on the landscape of AI tools for sepsis, approaches to selecting one, and best practices for their use. The session will first provide a research-backed overview of AI tools for sepsis, including a review of published performance data. The webinar will then feature a case study from Yale New Haven Health System, highlighting lessons learned in their experience comparing and implementing several different solutions over the past few years.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by AgileMD for this sponsored webinar.
Dana Edelson, MD, MS, FAHA, FHM (Moderator)
Co-founder & Chief Medical Officer
AgileMD
Dana Edelson, MD, MS, FAHA, FHM, is a physician scientist and Executive Medical Director for Rescue Care and Resiliency at the University of Chicago. She is an internationally recognized expert in cardiac arrest, sepsis, and rapid response systems, with a focus on harnessing artificial intelligence and machine learning (AI/ML) to identify subtle changes in clinical stability and drive clinical workflows to prevent failure to rescue in the hospital. Dr. Edelson is a co-inventor of eCART, an FDA cleared early warning tool, and co-founder of AgileMD, a health tech start-up which delivers eCART and other clinical decision support software to hundreds of hospitals across the U.S. She has received millions of dollars in federal research funding and has over 150 peer-reviewed publications that have been widely cited. Dr. Edelson was named by Becker’s Hospital Review as one of the Women in Medtech to Know and currently serves as on the American Heart Association Resuscitation Systems of Care Advisory Group.
Patrick G Lyons, MD, MSc
Assistant Professor of Medicine and Informatics
Oregon Health & Science University
Patrick G Lyons, MD, MSc, is an intensivist and healthcare delivery scientist at Oregon Health & Science University. He has expertise in data science, human-centered design, and implementation research methods. His lab focuses on data-driven innovations in recognizing, characterizing, treating, and communicating about critical illness syndromes in special populations, such as patients with cancer. He joined the Department of Medicine and the Department of Medical Informatics and Clinical Epidemiology at Oregon Health and Science University in 2022 after serving as the inaugural Medical Director of the Healthcare Innovation Lab at Washington University School of Medicine and BJC HealthCare in St. Louis.
Jennifer Johnson, APRN
Program Manager, Care Signature
Yale New Haven Health
Jennifer Johnson, APRN, is a critical care nurse practitioner at Yale New Haven Health Care, where she has gained extensive experience leading quality improvement efforts across a large health system. She’s developed expertise leading diverse groups to obtain consensus and change practice to be more evidence-based and data-oriented. Her work has led to improvements in outcomes, including reduction in mortality, improvements in length of stay, and cost savings. She co-leads Yale New Haven Health’s eCART initiative and works clinically in the Tele ICU.
Please feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this webinar/course.
Content provided by Baxter (No CE credits offered)
Webinar Description:
In this Baxter sponsored webinar, delve deeper into dynamic fluid responsiveness when resuscitating the hypotensive patient with sepsis. Nicole Kupchik will discuss how to use non-invasive stroke volume technology to guide fluid decisions in sepsis and septic shock.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided for this Sponsor Innovation Webinar by
Nicole Kupchik, MN, RN, CCNS, CCRN-CMC, PCCN, is a national and international speaker on several emergency and critical care topics. A critical care nurse for over 30 years, she earned a nursing degree from Purdue University and a Master of Nursing from University of Washington. Nicole has taught CCRN and PCCN certification review courses for over 15 years, authored numerous publications, and launched programs including Sepsis and Post Cardiac Arrest Hypothermia (TTM) and Quality Improvement in Resuscitation.
Nicole published seven books including the Critical Care Survival Guide as well as the “You Can Do It” book series, including Ace the CCRN, Ace the PCCN, Ace the CMC, and Ace the CSC.
She has won national awards including “Nurse of the Year” for advancing the nursing profession by the March of Dimes. For her work in sepsis, Nicole was awarded two Washington State Patient Safety awards. She was also nominated for the Sepsis Alliance “Sepsis Hero” Award for her extensive work in educating healthcare professionals about sepsis.
Please feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this webinar/course.
Learn how the new Z51.A code is crucial for healthcare providers to document follow-up care for sepsis survivors who may be at risk for recurrent infections or dealing with the long-term effects of sepsis, such as post-sepsis syndrome (PSS).
Description:
Date: October 30, 2024
Time: 2:00 - 3:00 pm ET
Sepsis affects over 1.7 million Americans each year and the Centers for Disease Control (CDC) reports that 75% of sepsis deaths in the U.S. occur in the Medicare population, with a death rate exceeding 300 per 100,000 people. Sepsis survivors face a higher risk of recurrence and readmission, particularly if they’ve been in intensive care. In July 2024, CMS released the FY 2025 ICD-10-CM code update, effective from October 1, 2024, to September 30, 2025. This update includes a new code, Z51.A ‘Encounter for Sepsis Aftercare,’ which allows providers to document sepsis aftercare and warn patients about potential risks, such as new or recurring infections, and offer rehabilitation for impairments.
In this informative presentation, Dr. Kathy Bowles will discuss how the new Z51.A code is crucial for healthcare providers to document follow-up care for sepsis survivors who may be at risk for recurrent infections or dealing with the long-term effects of sepsis, such as post-sepsis syndrome (PSS). It ensures that ongoing care, like monitoring for new infections or rehabilitation for impairments, is properly recorded.
Learning Objectives:
At the end of the activity, the learner should be able to:
Describe the use case for ICD-10 code Z51.A 'Encounter for Sepsis Aftercare;’
Identify the barriers to information transfer during transitions in care for sepsis survivors and suggest strategies for improvement;
Identify appropriate applications of ICD-10 code Z51.A in various healthcare settings.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Kathryn Bowles PhD, RN, FAAN, FACMI
Professor of Nursing, University of Pennsylvania School of Nursing
Director of the Center for Home Care Policy & Research, VNS Health
Kathryn Bowles PhD, RN, FAAN, FACMI, is a Professor of Nursing and the van Ameringen Chair in Nursing Excellence at the University of Pennsylvania School of Nursing. She is the Vice President and Director of the Center for Home Care Policy & Research at VNS Health. Her program of research in clinical decision support and implementation science for discharge planning, transitions in care, and home care with vulnerable older adults has been continuously funded for 25 years. She has served on many national committees and workgroups to advance the care of older Americans such as the National Quality Forum, the Care Coordination Steering Committee ,and the Heath Information Technology Standards Panel (HITSP) Care Coordination Committee. She was an invited expert consultant on the Centers for Medicare Services (CMS) Technical Expert Panel on the Post-Acute Care Assessment instrument (CARE tool) and two other Expert Panels to develop measures for transitions in care and continuity of care.
Dr. Bowles co-founded RightCare Solutions, a software company based on her team's research on decision support for post-acute care referrals. She was appointed to the National Institute of Nursing Research (NINR) Advisory Council and delivered the 2016 NINR Director's Lecture. She was invited by the National Academy of Medicine and the Office of the National Coordinator for Health Information Technology to discuss optimizing strategies for clinical decision support. She is a fellow in the American Academy of Nursing and the American College of Medical Informatics, a member of the American Nurses Association (ANA), and Sigma Theta Tau International Honor Society where she was inducted into the International Nursing Research Hall of Fame.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.2 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
Please feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this webinar/course.
Content provided by Spectral Medical (No CE credits offered)
Webinar Description:
What part does endotoxin play in the etiology of sepsis and septic shock? This sponsored webinar will describe the human response to elevated levels of endotoxin, both as an adaptive immune response and also as a trigger of sepsis. The ability to measure endotoxin activity in the bloodstream allows clinicians to uncloak its true prevalence and closely examine when endotoxin plays a role in sepsis. Can targeting endotoxin removal be a successful treatment modality for sepsis? Tune in to this webinar to learn more.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Spectral Medical for this sponsored webinar.
Debra Foster, BSc
Clinical Consultant
Spectral Medical
Debra M. Foster, BSc, spent 11 years as an RN in the adult critical care area. Thereafter, Debra joined the critical care clinical research team at Toronto General Hospital. She was project lead for a multi-national, multi-center clinical trial - the MEDIC study. The data was used for a successful 510(k) de novo submission to the FDA for the Endotoxin Activity Assay (EAA). It was the first IVD for sepsis. Debra went on to follow the device to its commercial partner, Spectral Medical, Inc. She became VP of Clinical Development in 2011. Debra led many clinical research projects, including the MEDIC, EUPHRATES, and TIGRIS clinical trials, aimed at endotoxin in critical illness. Currently, Debra is a clinical consultant for Spectral Medical. She has lectured to medical professionals on the topics of sepsis, endotoxin, and clinical trials for sepsis and has been a co-author of more than 50 articles in peer-reviewed journals.
Mark A. Tidswell, MD
Professor of Medicine
UMASS Chan Medical School – Baystate
Mark A. Tidswell, MD, is a Professor of Medicine at UMASS Chan Medical School – Baystate. Trained asa pulmonary and critical care physician, his clinical practice is adult critical care and neurocritical care at Baystate Medical Center in Springfield, MA. He began work in multi-center clinical trials 25 years ago. He was an active contributor to the NHLBI research networks ARDSnet and PETAL from 2000 – 2024, which studied thousands of patients with ARDS, sepsis, and COVID-19. He serves as site PI for pharmaceutical trials in the area of sepsis and ARDS and has 20 years of experience using the Endotoxin Activity Assay to identify endotoxemia in patients in clinical trials. Dr. Tidswell was an investigator in the EUPHRATES trial and is part of the scientific steering committee for the TIGRIS study. He is a co-author and contributor to more than 90 publications.
Please feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this webinar/course.
Annual, virtual conference covering sepsis-related topics and offering RN CE Contact Hours
To access the Sepsis Alliance Summit session recordings, click below to go to your dashboard. Then, click Advanced Search. Search by Type, and search for Conference Recordings.
*Over 49 million people worldwide affected each year.*
This is sepsis.
Join us to learn more about how you can help better identify, diagnose, and treat this deadly condition in your practice. Mortality increases 4-9% for every hour that treatment is delayed. YOU can help save lives and limbs by staying up-to-date on current recommendations and guidelines around sepsis by joining us at the 5th Annual Sepsis Alliance Summit.
For the first time, Sepsis Alliance Summit is joining forces with Sepsis Forum: Bench • Bedside • Beyond to offer a third day focused on global viewpoints on sepsis.
Are you ready to learn with us? Register today for this free, virtual conference. You’ll earn RN CE credits and improve your practice, benefiting sepsis patients.
FREE Nursing CE Credits Offered!
Continuing nursing education credits will be available, as will post-event access to resources, ideas, and innovations to improve sepsis care and antimicrobial stewardship. Sepsis Alliance is a Provider approved by the California Board of Registered Nursing for 15.0 contact hours, Provider Number CEP17068.
Conference Supporters:
Sepsis Alliance gratefully acknowledges the support provided for this conference by the following sponsors:
Agenda
September 25, 2024
Time (ET)
Session Title
Presenter
10:00-10:15
Opening Remarks & The 2024 Erin Kay Flatley Spirit Award Winners
Carl Flatley, DDS, MSD Founder, Sepsis Alliance
Jackie Duda Health and Travel Journalist Sepsis and Disability Advocate
Julia Fraser
Sepsis Survivor, Mrs. Texas
10:20-10:30
Day 1 Keynote: Advocacy and Awareness: Our Family's Journey with Sepsis and the Power of ‘Using Your Voice’
Jake Tapper Anchor and Chief Washington Correspondent, CNN
Alice Tapper Student & Patient Advocate
Jennifer Tapper Sepsis Alliance – Board of Directors
10:35-11:00
Recognizing the Overlooked: Identifying Features of Delayed Sepsis Diagnoses (CE Session)
Gary Garber, MD, FRCPC, FACP, FIDSA, CCPE Director, Safe Medical Care Research
Canadian Medical Protective Association
Eileen Bridges, MD, CCFP, MSc, Dip Sport Med. Senior Physician Advisor, Safe Medical Care Learning
Canadian Medical Protective Association
11:00-11:30
A Sepsis Documentation Journey: Memorial Hospital of Union County (Ohio) (CE Session)
Amy Stephens, MBA, RN, CPHQ, CHC Assistant Vice President of Quality and Compliance, Memorial Hospital
Robin Regula, RN Clinical Quality Specialist Memorial Hospital
11:30-12:00
Track 1: Recce Pharmaceuticals Sponsored Session: New Frontiers in Sepsis and Urosepsis Treatment: Synthetic Anti-Infectives to Combat Superbugs
Track 2: Abionic Sponsored Session: Rapid Sepsis Screening - Can Pancreatic Stone Protein (PSP) Enhance ED Triage?
Track 1: James Graham Managing Director & Chief Executive Officer, Recce Pharmaceuticals Track 2: Andrew Shorr, MD Section Director, Pulmonary and Critical Care Medicine, Medstar Washington Hospital Center (MWHC)
Evangelos J. Giamarellos-Bourboulis, MD, PhD Professor of Internal Medicine and Infectious Diseases, Medical School of the National and Kapodistrian University of Athens
Patrick Pestalozzi, MBA
Chief Executive Officer, Abionic
12:00-12:15
Break
12:15-12:45
Racial and Ethnic Disparities in Sepsis (CE Session)
Christopher F. Chesley, MD, MSCE Assistant Professor of Medicine
Perelman School of Medicine at the University of Pennsylvania
12:50-1:20
Post-Intensive Care Syndrome in Survivors of Sepsis (CE Session)
Tracye Proffitt, PhD, RN, CNE Assistant Professor Virginia Commonwealth University School of Nursing
1:25-1:55
bioMérieux Sponsored Session: Comprehensive Clinical Solution Throughout the Acute Care Patient Journey
Daniel Feinstein, MD, MS, FACP, ACRP-PI Director of Pulmonary Critical Care Medicine, Novant Healthcare
1:55-2:10
Break
2:10-2:40
Neonatal Sepsis: A Global Challenge (CE Session)
Pascal Lavoie, MDCM, PhD Professor of Pediatrics University of British Columbia
2:45-3:30
Sepsis: Threat to Cardiovascular Health (CE Session)
Mitchell S. V. Elkind, MD, MS FAHA
Chief Clinical Science Officer
American Heart Association
3:35-3:50
Track 1: Roche Sponsored Session: Immunotherapy of Sepsis Guided by Biomarkers
Track 2: Flosonics Medical Sponsored Session: Cracking SEP-1: Your Guide to Acing Fluid Administration Requirements
Track 1: Richard S. Hotchkiss, MD Professor of Anesthesiology, Medicine, and Surgery, Washington University School of Medicine
Track 2: Jaclyn Bond, MSN-LM, MBA-HM, RN Director of Nursing, Riverside University Health System
3:55-4:10
Track 1: InflaRx Sponsored Session: For Some Patients, COVID-19 Remains a Serious Threat
Track 2: SeaStar Medical Sponsored Session: Pediatric Sepsis, The Unique Fallout of a Global Killer
Track 1: Bruce P. Burnett, PhD VP, Head of Medical Affairs, InflaRx
Track 2: Rajit K. Basu, MD, MS, FCCM Division Chief of Critical Care Medicine Ann & Robert Lurie Children’s Hospital of Chicago
4:15-4:45
Advancing Health Equity for Sepsis Patients with Limited English Proficiency: Reducing Length of Stay and Readmissions (CE Session)
Day 2 Keynote: The Changing Climate of Infectious Diseases and Sepsis (CE Session)Reducing Harm Related to Sepsis and Infections
Matthew C. Phillips, MD, PhD Clinical and Research Fellow Massachussetts General Hospital
10:55-11:25
Reducing Harm Related to Sepsis and Infections (CE Session)
David W. Bates, MD, MSc
Co-Director Artificial Intelligence and Bioinformatics in the Learning Healthcare System Mass General Brigham
11:30-12:00
Track 1: Baxter Sponsored Session: Changing Landscape for Sepsis: Value-based Purchasing and The New CDC Hospital Sepsis Program Core Elements
Track 2: Wolters Kluwer Sponsored Session: The Human Impact of Sepsis Identification and Management
Track 1: Pat Posa, RN, BSN, MSA, CCRN, FAAN Quality and Safety Program Manager Hospital Medicine Safety (HMS) Coordinating Center, University of Michigan
Hospital Care at Home in the Continuum of Care for Sepsis (CE Session)
Grace Jenq, MD Clinical Professor, Geriatric and Palliative Medicine; Associate Chief Clinical Officer, Post-Acute Care Services
University of Michigan Medicine
12:50-1:20
Sepsis Patient Education as Quality Improvement (CE Session)
Bethany Koschel, DO Internal Medicine Physician Providence St. Vincent Internal Medicine
1:25-1:40
T2 Biosystems Sponsored Session: Advancing Sepsis Detection in ICUs: Assessing the Benefits and Integration of T2Candida in Clinical Practice
Cristian Merchan, Pharm.D., BCCCP Assistant Director of Clinical Pharmacy Services - Critical Care, Emergency and Perioperative Services NYU Langone Health
1:45-2:00
Track 1: Cytovale Sponsored Session: IntelliSep Revolutionizes Early Sepsis Detection: Real Cases and a Patient Story
Track 2: Inflammatix Sponsored Session: Advances in Emergency Medicine Diagnostic Testing: Reducing Clinical Ambiguity with Patients Suspected of Acute Infections or Sepsis
Track 1: Hollis (Bud) O'Neal, MD Associate Professor of Medicine Louisiana State University Health Sciences Center
Mark Laperouse, MD Medical Director Emergency Services Our Lady of the Lake Regional Medical Center
Track 2: Tim Sweeney, MD, PhD
Co-Founder and CEO
Inflammatix
2:00-2:15
Break
2:15-2:45
Sepsis in the Cardiac Intensive Care Unit: Early Goal-Directed Mechanical Circulatory Support? (CE Session)
Jonathan Ludmir, MD Assistant Professor of Medicine
Massachusetts General Hospital, Harvard Medical School
2:50-3:25
Earlier Recognition and Response to Critical Illness Outside the ICU (CE Session)
Frank Sebat, MS, MS, FCCM Director, Kritikus Foundation
3:30-3:55
Boston Scientific Sponsored Session: Intrarenal Pressure During Flexible Ureteroscopy
Manoj Monga, MD, FACS, FRCS
Professor and Chair of Department of Urology, University of California San Diego
Naeem Bhojani, MD Professor of Surgery
University of Montreal
Ben H. Chew, MD, MSc, FRCSC Associate Professor of Urology
University of British Columbia
4:00-4:15
Use of Virtual Reality for Sepsis Recognition and Management Training (CE Session)
Matthew Zackoff, MD, MEd Assistant Professor, Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center
4:20-4:30
Closing Remarks
September 27, 2024
For the first time, Sepsis Alliance is joining forces with Sepsis Forum: Bench • Bedside • Beyond to offer a third day focused on global viewpoints on sepsis.
Time (ET)
Session Title
Presenter
10:00-10:10
Opening Remarks and Land Acknowledgement
David Carlbom, MD
Associate Professor of Medicine, Pulmonary Critical Care and Sleep Medicine
University of Washington School of Medicine
Medical Director, Respiratory Care Department
Attending Physician, Medical and Trauma-Surgical Intensive Care Units
Harborview Medical Center
Katy Grainger
Sepsis Survivor and Advocate
10:10-10:55
Session 1: Implementation of Pediatric Sepsis Phoenix Criteria Across the Globe: Building Equity?
10:10-10:15 Introductions
10:15-10:30 Development of the Phoenix Criteria for Sepsis and Septic Shock in Children 10:30-10:45 The Phoenix Pediatric Sepsis Definitions - Applying Them in South Africa 10:45-10:55 Panel Discussion
Moderator: Scott P. Sherry, MS, PA-C, FCCM Sepsis Program Manager, Oregon Health and Science UniversityDoernbecher Children’s Hospital
Nelson Sanchez-Pinto, MD, MBI, FAMIA Northwestern University - Feinberg
School of Medicine
Andrew Argent, MBBCh, MMed, MD, FRCPCH (UK)
11:00-11:55
Session 2: Challenges & Opportunities for Improving Maternal Sepsis Care
11:00-11:05 Introductions 11:05-11:18 Midwives’ role in preventing maternal and neonatal sepsis in Low- and Middle-Income Countries 11:18-11:31 Addressing Maternal Sepsis: A Large-Scale Quality Improvement Approach 11:31-11:44 Practical approaches to addressing maternal sepsis in Low-to-Middle Income Countries 11:44-11:55 Panel Discussion
Moderator: Scott P. Sherry, MS, PA-C, FCCM Sepsis Program Manager, Oregon Health and Science University Doernbecher Children’s Hospital
Cathryn Ellis. BFA, MSc. PhD, RM (non-practicing) Associate Professor Emeritus University of British Columbia
Elliott K. Main, MD Professor of Obstetrics and Gynecology
Stanford University School of Medicine
María Fernanda Escobar Vidarte, MD
Chief of the Global Health Equity Unit
Fundacion Valle del Lili
12:00-12:30
Break
12:30-1:30
Session 3: Bedside Education - Teaching Providers How to Apply Best Practices
12:30-12:35 Introductions 12:35-12:53 The Hard Part - Turning Guidelines Into Practice 12:53-1:11 Transformational Leadership: People-Centered Framework to Address Antimicrobial Resistance, the Silent Tsunami! 1:11-1:25 Panel Discussion
Session 4: Bench to Bedside: Updates in Sepsis Science
1:30-1:35 Introductions 1:35-2:20 Sepsis Research Update: Considerations for All Care Settings 2:20-2:25 Q&A
Moderator: Mary Jo Kelly DNP, ARNP-CNS, CCNS, CCRN
Elizabeth Bridges PhD, RN, CCNS, FCCM, FAAN
University of Washington Medical Center
2:30-3:25
Session 5: Sepsis Survivorship
2:30-2:35 Introductions 2:35-2:43 Journey to Sepsis Survivorship: Patient Perspective 2:43-2:56 Sepsis Aftercare: Improving the Lives of Sepsis Survivors 2:56-3:09 Sepsis Transition and Recover (STAR), Nurse Navigators Delivering Best Practice Post-Discharge Care 3:09-3:25 Panel Discussion
Moderator: Sybil Hoiss, RN, MN Lead, Clinical Initiatives & Innovation
Critical Care BC, Provincial Health Services Authority
Hailey Bain Sepsis Survivor and Patient Partner
Sepsis Canada
Mark E. Mikkelsen, MD, MSCE, FCCM Associate Chief Medical Officer, Critical Care
University of Colorado Hospital
Stephanie Taylor, MD, MS
Division Chief of Hospital Medicine
University of Michigan
Content provided by bioMérieux (No CE credits offered)
Webinar Description:
Join us for a sponsored webinar on “The Impact of Prioritizing Sepsis Management and Diagnostic Stewardship in the C-Suite,” where we will delve into the critical importance of executive leadership in enhancing sepsis care. This session will explore the seven core elements of a robust sepsis program, the implementation of the 3- and 6-hour sepsis bundles, and the pivotal role of diagnostics in early detection and treatment. Attendees will gain a comprehensive understanding of current best practices and strategies, as well as a forward-looking perspective on the future of sepsis care, ensuring improved patient outcomes and operational efficiency.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by bioMérieux for this sponsored webinar.
Minkey Wungwattana, PharmD, BCIDP
Field Medical Director, U.S. Medical Affairs
bioMérieux
Minkey Wungwattana, PharmD, BCIDP, is a Field Medical Director with bioMérieux. He received his Doctor of Pharmacy degree from Purdue University in 2011 and completed his post-graduate residency training in infectious diseases at Indiana University Health in Indianapolis, IN. After the completion of residency training, he became the Antimicrobial Stewardship Program (ASP) director at Maine Medical Center in Portland, ME. He was successful at implementing rapid diagnostic platforms during his 10 years of clinical practice at Maine Health. His areas of interest include optimizing the outcomes of infectious diseases patients with limited resources, diagnostic stewardship, and myth busting outdated infectious disease dogmas.
